FDA approves Promus Premier stent system
Candace Stuart | November 25, 2013 | Cardiovascular Business | Interventional Cardiology

The FDA has given Boston Scientific the green light to market its next-generation durable polymer drug-eluting stent in the U.S.

The agency approved the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System for treating patients with coronary artery disease. According to the Natick, Mass.-based company, the stent provides a platinum chromium alloy stent architecture, everolimus drug and a biocompatible, fluorinated co-polymer coating.

The stent system offers a low-profile delivery system with a shorter tip, a dual-layer balloon and an inner lumen catheter designed to facilitate stent delivery.  

The Promus stent has been evaluated in several studies. At the 2013 Transcatheter Cardiovascular Therapeutics scientific session in San Francisco, for instance, a clinical trial designed to compare Promus Element and Resolute Integrity (Medtronic) stents found them to be comparable for safety and efficacy.

The Promus Premier Stent System is offered in a matrix of sizes ranging in diameter from 2.25 mm to 4 mm and lengths of 8 mm to 38 mm. The Promus Premier stent received CE Mark approval earlier this year.

Candace Stuart, Contributor

Related Content

TAVR or SAVR? ChatGPT could help cardiologists decide
Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
Boston Scientific recalls premixed embolic agent after two deaths
New cardiac imaging strategy could reduce ICA, PCI rates
Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup